These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 16950226

  • 1. Enhanced preproenkephalin-B-derived opioid transmission in striatum and subthalamic nucleus converges upon globus pallidus internalis in L-3,4-dihydroxyphenylalanine-induced dyskinesia.
    Aubert I, Guigoni C, Li Q, Dovero S, Bioulac BH, Gross CE, Crossman AR, Bloch B, Bezard E.
    Biol Psychiatry; 2007 Apr 01; 61(7):836-44. PubMed ID: 16950226
    [Abstract] [Full Text] [Related]

  • 2. Effect of non-dopaminergic drug treatment on Levodopa induced dyskinesias in MPTP monkeys: common implication of striatal neuropeptides.
    Tamim MK, Samadi P, Morissette M, Grégoire L, Ouattara B, Lévesque D, Rouillard C, Di Paolo T.
    Neuropharmacology; 2010 Jan 01; 58(1):286-96. PubMed ID: 19576910
    [Abstract] [Full Text] [Related]

  • 3. Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia.
    Johansson PA, Andersson M, Andersson KE, Cenci MA.
    Neurobiol Dis; 2001 Apr 01; 8(2):220-39. PubMed ID: 11300719
    [Abstract] [Full Text] [Related]

  • 4. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
    Henry B, Crossman AR, Brotchie JM.
    Exp Neurol; 1999 Feb 01; 155(2):204-20. PubMed ID: 10072296
    [Abstract] [Full Text] [Related]

  • 5. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA.
    Cenci MA, Lee CS, Björklund A.
    Eur J Neurosci; 1998 Aug 01; 10(8):2694-706. PubMed ID: 9767399
    [Abstract] [Full Text] [Related]

  • 6. Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalin.
    Morissette M, Dridi M, Calon F, Hadj Tahar A, Meltzer LT, Bédard PJ, Di Paolo T.
    Mov Disord; 2006 Jan 01; 21(1):9-17. PubMed ID: 16127720
    [Abstract] [Full Text] [Related]

  • 7. Ropinirole versus L-DOPA effects on striatal opioid peptide precursors in a rodent model of Parkinson's disease: implications for dyskinesia.
    Ravenscroft P, Chalon S, Brotchie JM, Crossman AR.
    Exp Neurol; 2004 Jan 01; 185(1):36-46. PubMed ID: 14697317
    [Abstract] [Full Text] [Related]

  • 8. Enhanced striatal opioid receptor-mediated G-protein activation in L-DOPA-treated dyskinetic monkeys.
    Chen L, Togasaki DM, Langston JW, Di Monte DA, Quik M.
    Neuroscience; 2005 Jan 01; 132(2):409-20. PubMed ID: 15802193
    [Abstract] [Full Text] [Related]

  • 9. Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease.
    Visanji NP, Fox SH, Johnston T, Reyes G, Millan MJ, Brotchie JM.
    Neurobiol Dis; 2009 Aug 01; 35(2):184-92. PubMed ID: 19118628
    [Abstract] [Full Text] [Related]

  • 10. Changes in glutamate receptors in dyskinetic parkinsonian monkeys after unilateral subthalamotomy.
    Jourdain VA, Morin N, Grégoire L, Morissette M, Di Paolo T.
    J Neurosurg; 2015 Dec 01; 123(6):1383-93. PubMed ID: 25932606
    [Abstract] [Full Text] [Related]

  • 11. Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease.
    Henry B, Duty S, Fox SH, Crossman AR, Brotchie JM.
    Exp Neurol; 2003 Oct 01; 183(2):458-68. PubMed ID: 14552886
    [Abstract] [Full Text] [Related]

  • 12. ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice.
    Pavón N, Martín AB, Mendialdua A, Moratalla R.
    Biol Psychiatry; 2006 Jan 01; 59(1):64-74. PubMed ID: 16139809
    [Abstract] [Full Text] [Related]

  • 13. Long-term treatment with l-DOPA and an mGlu5 receptor antagonist prevents changes in brain basal ganglia dopamine receptors, their associated signaling proteins and neuropeptides in parkinsonian monkeys.
    Morin N, Jourdain VA, Morissette M, Grégoire L, Di Paolo T.
    Neuropharmacology; 2014 Apr 01; 79():688-706. PubMed ID: 24456747
    [Abstract] [Full Text] [Related]

  • 14. Repeated administration of piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: a behavioural and biochemical investigation.
    Smith LA, Tel BC, Jackson MJ, Hansard MJ, Braceras R, Bonhomme C, Chezaubernard C, Del Signore S, Rose S, Jenner P.
    Mov Disord; 2002 Sep 01; 17(5):887-901. PubMed ID: 12360537
    [Abstract] [Full Text] [Related]

  • 15. Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
    Calon F, Lavertu N, Lemieux AM, Morissette M, Goulet M, Grondin R, Blanchet PJ, Bédard PJ, Di Paolo T.
    Synapse; 2001 Jun 01; 40(3):225-34. PubMed ID: 11304760
    [Abstract] [Full Text] [Related]

  • 16. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
    Carta AR, Frau L, Pinna A, Pontis S, Simola N, Schintu N, Morelli M.
    Synapse; 2008 Jul 01; 62(7):524-33. PubMed ID: 18435422
    [Abstract] [Full Text] [Related]

  • 17. Different functional basal ganglia subcircuits associated with anti-akinetic and dyskinesiogenic effects of antiparkinsonian therapies.
    Lacombe E, Khaindrava V, Melon C, Oueslati A, Kerkerian-Le Goff L, Salin P.
    Neurobiol Dis; 2009 Oct 01; 36(1):116-25. PubMed ID: 19615446
    [Abstract] [Full Text] [Related]

  • 18. Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
    Fox SH, Henry B, Hill M, Crossman A, Brotchie J.
    Mov Disord; 2002 Nov 01; 17(6):1180-7. PubMed ID: 12465055
    [Abstract] [Full Text] [Related]

  • 19. Altered D(1) dopamine receptor trafficking in parkinsonian and dyskinetic non-human primates.
    Guigoni C, Doudnikoff E, Li Q, Bloch B, Bezard E.
    Neurobiol Dis; 2007 May 01; 26(2):452-63. PubMed ID: 17350277
    [Abstract] [Full Text] [Related]

  • 20. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.
    Muñoz A, Li Q, Gardoni F, Marcello E, Qin C, Carlsson T, Kirik D, Di Luca M, Björklund A, Bezard E, Carta M.
    Brain; 2008 Dec 01; 131(Pt 12):3380-94. PubMed ID: 18952677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.